Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06419322 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Acceptability, Feasibility, Safety and Efficacy of a Optimized Rehabilitation Program for Treated Patients With Spinal Muscular Atrophy (SMA).

Name: Acceptability, Feasibility, Safety and Efficacy of a Optimized Rehabilitation Program for Treated Patients With Spinal Muscular Atrophy (SMA). — clinical trial record (NCT06419322)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: ACE SMA

StatusCompleted

PhaseNot applicable

SponsorUniversity of Oxford

Started2024-06-01

View on ClinicalTrials.gov ↗

The goal of this study is to investigate the acceptability, feasibility, safety and efficacy of an optimized rehabilitation program for treated patients with spinal muscular atrophy (SMA) compared to the current rehabilitation program in the United Kingdom. The aim is to provide patients with more hands on physiotherapy and access to rehabilitation devices at home to support parents currently providing rehabilitation on their own.

Amendment history 2 changes detected by DataLookout

2026-09-16

Trial completed

2026-09-16

Study completion confirmed: August 2026 (last estimated December 2026)

Trial Details

NCT Number	NCT06419322
Lead Sponsor	University of Oxford Collaborators: Oxford Brookes University, Oxford University Hospitals NHS Trust, ACE SMA Charity, Roche Products Limited, Scholar Rock, Inc., Biohaven Therapeutics Ltd., Rally Round Rupert Charity
Conditions	Spinal Muscular Atrophy
Enrollment	14 participants
Start Date	2024-06-01
Primary Completion	2026-06-30 (estimated)
Study Completion	2026-08-31 (estimated)
Updated on ClinicalTrials.gov	2026-09-15